Cargando…
Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation
BACKGROUND: Phosphoglucomutase 1 (PGM1) acts as an important regulator in glucose metabolism. However, the role of PGM1 in gastric cancer (GC) remains unclear. This study aims to investigate the role of PGM1 and develop novel regimens based on metabolic reprogramming in GC. METHODS: Correlation and...
Autores principales: | Cao, Bo, Deng, Huan, Cui, Hao, Zhao, Ruiyang, Li, Hanghang, Wei, Bo, Chen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434706/ https://www.ncbi.nlm.nih.gov/pubmed/34507580 http://dx.doi.org/10.1186/s12935-021-02193-3 |
Ejemplares similares
-
Glucose starvation suppresses gastric cancer through targeting miR-216a-5p/Farnesyl-Diphosphate Farnesyltransferase 1 axis
por: Zhao, Ruiyang, et al.
Publicado: (2021) -
Inhibition of androgen receptor enhanced the anticancer effects of everolimus through targeting glucose transporter 12
por: Cao, Bo, et al.
Publicado: (2023) -
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
por: Sun, Yifan, et al.
Publicado: (2019) -
PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
por: Zheng, Zhewen, et al.
Publicado: (2022) -
circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis
por: Li, Hanghang, et al.
Publicado: (2022)